HHS Announces Opioid Use Disorder Funding Opportunities
The U.S. Department of Health and Human Services (HHS), through the Substance Abuse and Mental Health Services Administration (SAMHSA), recently announced two new grant programs totaling $25.6 million to expand access to medication-assisted treatment for opioid use disorder and prevent the misuse of prescription drugs. The funding opportunities reflect priorities of the HHS Overdose Prevention Strategy and new efforts to strengthen the country’s mental health and crisis care systems.
The two grant programs are:
- Strategic Prevention Framework for Prescription Drugs (SPF Rx) – Provides funds for state agencies, territories, and tribal entities that have completed a Strategic Prevention Framework State Incentive Grant plan or similar state plan to target prescription drug misuse. The grant program will raise awareness about the dangers of sharing medications, fake or counterfeit pills sold online, and overprescribing. The grant will fund a total of $3 million over five years for up to six grantees.
- Medication-Assisted Treatment – Prescription Drug and Opioid Addiction (MAT-PDOA) – Provides resources to help expand and enhance access to Medications for Opioid Use Disorder (MOUD) and help increase the number of individuals with opioid use disorder (OUD) receiving MOUD and decrease illicit opioid use and prescription opioid misuse. The grant will fund a total of $22.6 million over five years for up to 30 grantees. No less than $11 million will be awarded to Native American tribes, tribal organizations, or consortia.
Additional information on the two funding opportunities is available here.